Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

TBTC Study 25: Study of the Tolerability of Higher Doses of Rifapentine in the Treatment of Tuberculosis

This study has been completed.
Sponsor:
Collaborator:
VA Office of Research and Development
Information provided by:
Centers for Disease Control and Prevention
ClinicalTrials.gov Identifier:
NCT00023426
First received: September 6, 2001
Last updated: September 9, 2005
Last verified: September 2005